LeBlanc, Amy
Mazcko, Christina N.
Mason, Nicola J.
Chambers, M. Renee
Brockington, David M.
Pluhar, G. Elizabeth
Naik, Shruthi
Funding for this research was provided by:
National Cancer Institute
Article History
Received: 9 December 2024
Accepted: 18 January 2025
First Online: 14 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: AL is co-Editor-in-Chief of this journal, and recused herself from all decisions about this paper. S. Naik and Mayo Clinic have a financial conflict of interested related to studies utilizing oncolytic Vesicular stomatitis virus. S. Naik is an inventor on patents related to oncolytic Vesicular stomatitis virus that has been licensed by Mayo Clinic to Vyriad, Inc. S. Naik has equity interests in Vyriad, Inc.